Advertisement

Palliation of abdominal symptoms

  • Nigel Sykes
Chapter
Part of the Cancer Treatment and Research book series (CTAR, volume 100)

Abstract

Constipation has been defined objectively in various ways, but its importance lies in the distress it causes as a symptom. The components of this symptom are primarily difficult and infrequent defecation, but may also include such sensations as flatulence, bloating, rectal dissatisfaction, and malaise.

Keywords

Palliative Care Magnesium Hydroxide Fecal Impaction Hospice Patient Hyoscine Butylbromide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cartwright A, Hockey L, Anderson JL. 1973. Life Before Death. London: Routledge and Kegan Paul, 23.Google Scholar
  2. 2.
    Holmes S. 1989. Use of a modified symptom distress scale in assessment of the cancer patient. Int J Nurs Stud 26:69–79.PubMedCrossRefGoogle Scholar
  3. 3.
    Sykes NP. 1990. Methods of assessment of bowel function in patients with advanced cancer. Palliat Med 4:287–292.CrossRefGoogle Scholar
  4. 4.
    Bassotti G, Gaburri M. 1988. Manometric investigation of high amplitude propagated contractile activity of the human colon. Am J Physiol 255:G660–G664.PubMedGoogle Scholar
  5. 5.
    Holdstock DJ, Misiewicz JJ, Smith T, Rowlands EH. 1970. Propulsion (mass movements) in human colon and its relation to meals and somatic activity. Gut 2:91–99.CrossRefGoogle Scholar
  6. 6.
    Wigzell FW. 1969. The health of nonagenarians. Gerontol Clin 11:137–144.CrossRefGoogle Scholar
  7. 7.
    Adler HF, Atkinson AJ, Ivy AC. 1942. Effect of morphine and dilaudid on the ileum and of morphine, dilaudid and atropine on the colon of man. Arch Intern Med 69:974–985.CrossRefGoogle Scholar
  8. 8.
    Margolin S. 1954. Decreased gastrointestinal propulsive activity after instracranial morphine. Fed Proc 13:383–384.Google Scholar
  9. 9.
    Manara L, Bianchi G, Ferretti P, Tavani A. 1986. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Ther 237:945–948.PubMedGoogle Scholar
  10. 10.
    Manara L, Bianchi G, Ferretti P, Monferini E, Strada D, Tavani A. 1980. Local and CNS-mediated effects of morphine and narcotic antagonists on gastrointestinal propulsion in rats. In Way EL (ed), Endogenous and Exogenous Opiate Agonists and Antagonists. New York: Pergamon, 143–146.Google Scholar
  11. 11.
    Ruppin H. 1987. Review: loperamide — a potent antidiarrhoeal drug with actions along the alimentary tract. Aliment Pharmacol Ther 1:179–190.PubMedCrossRefGoogle Scholar
  12. 12.
    Kreek MJ, Schaefer RA, Hahn EF, Fishman J. 1983. Naloxone, a specific opioid antagonist reverses chronic idiopathic constipation. Lancet i:261–262.CrossRefGoogle Scholar
  13. 13.
    Kreek MJ, Paris P, Bartol MA, Mueller D. 1984. Effects of short term oral administration of the specific opioid antagonist naloxone on faecal evacuation in geriatric patients. Gastroenterology 86:1144.Google Scholar
  14. 14.
    Connell AM, Hilton C, Irvine G, Lennard-Jones JE, Misiewicz JJ. 1965. Variation in bowel habit in two population samples. Br Med J ii: 1095–1099.CrossRefGoogle Scholar
  15. 15.
    Wyman JB, Mann JB, Heaton KW, Manning AP, Wicks ACB. 1978. Variability of colonic function in healthy subjects. Gut 19:146–150.PubMedCrossRefGoogle Scholar
  16. 16.
    Bruera E, Brenneis C, Michaud M, MacDonald N. 1987. Continous s.c. infusion of metoclopromide for treatment of narcotic bowel syndrome. Cancer Treat Rep 71:1121–1122.PubMedGoogle Scholar
  17. 17.
    Donaldson AN. 1922. Experimental study of intestinal stasis. JAMA 78:884–888.CrossRefGoogle Scholar
  18. 18.
    Mumford SP. 1986. Can high fibre diets improve the bowel function in patients on radiotherapy ward? Cited in Twycross RG, Lack SA, Control of Alimentary Symptoms in Far Advanced Cancer. London: Churchill Livingstone, 166–207.Google Scholar
  19. 19.
    Twycross RG, Lack SA. 1986. Control of Alimentary Symptoms in Far Advanced Cancer. London: Churchill Livingstone.Google Scholar
  20. 20.
    Sykes NP. 1996. A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Manage 11:363–369.PubMedCrossRefGoogle Scholar
  21. 21.
    Sykes NP. 1991 Clinical comparison of laxatives in a hospice. Palliat Med 5:307–314.CrossRefGoogle Scholar
  22. 22.
    Maguire LC, Yon JL, Miller E. 1981 Prevention of narcotic-induced constipation. N Eng J Med 305:1651Google Scholar
  23. 23.
    Debognie JC, Phillips SF. 1978. Capacity of the human colon to absorb fluid. Gastroenterology 74:698–703.Google Scholar
  24. 24.
    Condon JR, South M, Wolveson RL, Brinkley D. 1978. Radiation diarrhoea and cholestryramine. Postgrad Med J 54:838–839.CrossRefGoogle Scholar
  25. 25.
    Mennie AT, Dalley VM, Dinneen LC, Collier HO. 1975. Treatment of radiation-induced gastrointestinal distress with acetylsalicylate. Lancet ii:942–943.CrossRefGoogle Scholar
  26. 26.
    Edes TD, Walk BE, Austin JL. 1990. Diarrhoea in tube-fed patients: feeding formula not necessarily the cause. Am J Med 88:91–93.PubMedCrossRefGoogle Scholar
  27. 27.
    Mercadante S. 1992. Treatment of diarrhoea due to enterocolic fistula in a terminal cancer patient. Palliat Med 6:257–259.CrossRefGoogle Scholar
  28. 28.
    Boyd K. 1993. Diabetes mellitus in hospice patients: some guidelines. Palliat Med 7:163–164.PubMedCrossRefGoogle Scholar
  29. 29.
    Bruera E, Catz Z, Hooper R, Leattle B, MacDonald N. 1987. Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction. J Pain Symptom Manage 2:19–21PubMedCrossRefGoogle Scholar
  30. 30.
    Fainsinger RL, MacEachern T, Miller MJ, Bruera E, Spachynski K, Kuehn N, Hanson J. 1994. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 9:298–302.PubMedCrossRefGoogle Scholar
  31. 31.
    Mercadante S. 1995. Diarrhoea in terminally ill patients, pathophysiology and treatment. J Pain Symptom Manage 10:298–309.PubMedCrossRefGoogle Scholar
  32. 32.
    Norton JA, Doppman JL, Jensen RT. 1989. Cancer of the endocrine system. In De Vita VT, Hellman S, Rosenberg SA (eds), Cancer: Principles and Practice of Oncology, 3rd ed. Philadelphia: Lippincott, 1269-344.Google Scholar
  33. 33.
    DuPont HL, Ericsson CD, DuPont MW, Luna AC, Mathewson JJ. 1990. A randomized, open-label comparison of non-prescription loperamide and attapulgite in the symptomatic treatment of acute diarrhoea. Am J Med 88(Suppl 6A):205–235.Google Scholar
  34. 34.
    De Conno F, Caraceni A, Zecca E, Spoldi E, Ventafridda V. 1991 Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 6:484–486.PubMedCrossRefGoogle Scholar
  35. 35.
    Fedorak RN, Field M, Chang EB. 1985. Treatment of diabetic diarrhoea with Clonidine. Annals of Internal Medicine 102:197–199.PubMedGoogle Scholar
  36. 36.
    Hanks G, Portenoy RK, MacDonald N, Forbes K. 1998. Difficult pain problems. In Doyle D, Hanks G, MacDonald N (eds), Oxford Textbook of Palliative Medicine (2nd edition). Oxford: University Press, 464.Google Scholar
  37. 37.
    World Health Organisation Cancer Pain Relief. (2nd edition). Geneva: WHO, 1996.Google Scholar
  38. 38.
    Zenz M, Strumpf M, Tryba M. 1992. Long-term opioid therapy in patients with chronic non-malignant pain. Journal of Pain and Symptom Management 7:69–77.PubMedCrossRefGoogle Scholar
  39. 39.
    Boquet J, Moore N, Lhuintre JP, Boismare F. 1986. Diltiazem for proctalgia fugax. Lancet 1:1493.PubMedCrossRefGoogle Scholar
  40. 40.
    Bristow A, Foster JMG. 1988. Lumbar sympathectomy in the management of rectal tenesmoid pain. Annals of the Royal College of Surgeons of England 70:38–39.PubMedGoogle Scholar
  41. 41.
    Cutrin Prieto C, Casal Iglesias L, Batalla Eiras A, et al. 1991 Treatment with indomethacin for the control of metabolic disorder caused by a villous adenoma of the rectum. Annales de Medicina Interna 8:345–346.Google Scholar
  42. 42.
    Brunetaud JM, Maunoury V, Cochelard D, Adenis A, Boniface B, Cortot A, Paris JC. 1989. Lasers in rectosigmoid cancers: factors affecting immediate and long term results. Bailliere’s Clinical Gastroenterology 3:615–626.PubMedCrossRefGoogle Scholar
  43. 43.
    Abel ME, Chiu YS, Russell TR, Volpe PA. 1993. Autologous fibrin glue in the treatment of rectovaginal and complex fistulas. Diseases of the Colon and Rectum 36:447–449.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Nigel Sykes

There are no affiliations available

Personalised recommendations